Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Medical Cannabis and Wellness Equity |
| Investeringsfocus | Aandelen, Noord-Amerika, Gezondheidszorg |
| Fondsgrootte | EUR 9 m |
| Totale kostenratio (TER) | 0,80% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | No |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | - |
| Startdatum/Noteringsdatum | 9 januari 2020 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | HANetf |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | J.P. Morgan Administration Services (Ireland) Limited |
| Beleggingsadviseur | |
| Bewaarbank | J.P. Morgan SE - Dublin Branch |
| Revisiebedrijf | Ernst and Young |
| Einde belastingjaar | 31 maart |
| Vertegenwoordiger van Zwitserland | Waystone |
| Zwitserse uitbetalende instantie | Helvetische Bank AG |
| Duitsland | Onbekend |
| Zwitserland | Geen ESTV-rapportage |
| Oostenrijk | Niet-belastingplichtig fonds |
| UK | UK-rapportage |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
| Jazz Pharmaceuticals | 20,89% |
| Innovative Industrial | 14,39% |
| Scotts Miracle-Gro Co. | 14,28% |
| AMYRIS ORD | 11,94% |
| ARENA PHARMACEUTICALS ORD | 10,58% |
| GrowGeneration | 6,82% |
| Hydrofarm Holdings Group | 5,33% |
| CARA Therapeutics | 1,70% |
| 22ND CENTURY GROUP ORD | 1,41% |
| AGRIFY ORD SHS | 1,08% |
| Verenigde Staten | 74,01% |
| Ierland | 20,89% |
| Canada | 2,26% |
| Israël | 1,06% |
| Gezondheidszorg | 39,41% |
| Grondstoffen | 26,88% |
| Vastgoed | 14,73% |
| Industrie | 7,42% |
| Anders | 11,56% |
| YTD | - |
| 1 month | +0.00% |
| 3 months | +16.80% |
| 6 months | -7.08% |
| 1 year | - |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | - |
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | - |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | - |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | - |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | - |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| XETRA | EUR | CBSX | CBSXIV | CBSXEURINAV=SOLA | Goldenberg Hehemeyer LLP |